# Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

> **NCT05654922** · PHASE3 · RECRUITING · sponsor: **Renovion, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Pre-Bronchiolitis Obliterans Syndrome

## Interventions

- **DRUG:** ARINA-1
- **OTHER:** Standard of care only

## Key facts

- **NCT ID:** NCT05654922
- **Lead sponsor:** Renovion, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-10
- **Primary completion:** 2026-05
- **Final completion:** 2026-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05654922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05654922, "Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05654922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*